A Comparative assessment of Metabolic Syndrome and its association with Vitamin D and other risk factors in Type 2 Diabetes Mellitus Patients.
CONCLUSION: the study revealed high prevalence rate of metabolic syndrome among type 2 diabetic patients, which was highest 87.3% according to IDF and lowest was observed in WHO criteria 48.1%. A significant variance in the prevalence of metabolic syndrome was reported between WHO, IDF and NCEP criteria.
PMID: 32674733 [PubMed - as supplied by publisher]
Source: Current Diabetes Reviews - Category: Endocrinology Authors: Jairoun AA, Shahwan MJ, Khattab MH Tags: Curr Diabetes Rev Source Type: research
More News: Cholesterol | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Education | Endocrinology | Health Management | International Medicine & Public Health | Laboratory Medicine | Metabolic Syndrome | Statistics | Study | Sugar | Universities & Medical Training | Vitamin D | Vitamins | WHO